Redhill Biopharma News

Redhill Biopharma | D: Filing D

Feb 5 21:02

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.0%),Daniel B. Asher(4.0%), etc.

Feb 3 05:15

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(5.9%),Heights Capital Management, Inc.(5.9%)

Feb 1 23:26

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(3.19%),Ryan M. Lane(3.19%), etc.

Jan 8 13:00

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Jan 2 13:00

Redhill Biopharma | D: Filing D

Oct 13, 2023 04:05

Redhill Biopharma | D: Filing D

Aug 8, 2023 04:05

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Management, LP(6.12%),Ryan M. Lane(6.12%), etc.

Jan 13, 2023 21:04

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals

Jan 4, 2023 22:09

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cosmo Pharmaceuticals N.V.(13.2%),Cosmo Technologies Ltd.(13.2%)

Mar 8, 2022 06:25

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ibex Investors LLC(0.3%),Justin B. Borus(0.3%), etc.

Jan 28, 2022 05:31

Redhill Biopharma | D: Filing D

Nov 23, 2021 05:59

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 16, 2021 00:19

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 13, 2020 22:55

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 28, 2020 05:27

Redhill Biopharma | D: Filing D

Nov 7, 2019 03:34

Redhill Biopharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Jun 18, 2019 05:01

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 20, 2019 01:53

Redhill Biopharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 19, 2019 22:30

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 15, 2019 00:43